Publications:

---

Efficacy and clinicogenomic correlates of response to immune checkpoint inhibitors alone or with chemotherapy in non-small cell lung cancer.

Nature Communications

Hong, Lingzhi L; Aminu, Muhammad M; Li, Shenduo S; Lu, Xuetao X; Petranovic, Milena M; Saad, Maliazurina B MB; Chen, Pingjun P; Qin, Kang K; Varghese, Susan S; Rinsurongkawong, Waree W; Rinsurongkawong, Vadeerat V; Spelman, Amy A; Elamin, Yasir Y YY; Negrao, Marcelo V MV; Skoulidis, Ferdinandos F; Gay, Carl M CM; Cascone, Tina T; Gandhi, Saumil J SJ; Lin, Steven H SH; Lee, Percy P PP; Carter, Brett W BW; Wu, Carol C CC; Antonoff, Mara B MB; Sepesi, Boris B; Lewis, Jeff J; Gibbons, Don L DL; Vaporciyan, Ara A AA; Le, Xiuning X; Jack Lee, J J; Roy-Chowdhuri, Sinchita S; Routbort, Mark J MJ; Gainor, Justin F JF; Heymach, John V JV; Lou, Yanyan Y; Wu, Jia J; Zhang, Jianjun J; Vokes, Natalie I NI

Publication Date: 2023-02-08

Variant appearance in text: PIK3CA: 3085G>A; D1029N

PubMed Link: 36755027

Variant Present in the following documents:

• 41467_2023_36328_MOESM7_ESM.xlsx, sheet 1

View BVdb publication page

---

Predictive mutation signature of immunotherapy benefits in NSCLC based on machine learning algorithms.

Frontiers In Immunology

Liu, Zhichao Z; Lin, Guo G; Yan, Zeping Z; Li, Linduo L; Wu, Xingchen X; Shi, Jingrong J; He, Jianxing J; Zhao, Lei L; Liang, Hengrui H; Wang, Wei W

Publication Date: 2022

Variant appearance in text: PIK3CA: 3085G>A; D1029N

PubMed Link: 36238300

Variant Present in the following documents:

• Table_1.xlsx, sheet 4

View BVdb publication page

---

EPHA5 mutation was associated with adverse outcome of atezolizumab treatment in late-stage non-small cell lung cancers.

Bmc Pulmonary Medicine

Li, Zhenxiang Z; Zhou, Qing Q; Wang, Qi Q; Wang, Haiyong H; Yue, Weiming W

Publication Date: 2022-09-19

Variant appearance in text: PIK3CA: 3085G>A; D1029N

PubMed Link: 36123678

Variant Present in the following documents:

• 12890_2022_2161_MOESM2_ESM.xlsx, sheet 1

View BVdb publication page

---

Comprehensive molecular profiling of Taiwanese breast cancers revealed potential therapeutic targets: prevalence of actionable mutations among 380 targeted sequencing analyses.

Bmc Cancer

Huang, Chi-Cheng CC; Tsai, Yi-Fang YF; Liu, Chun-Yu CY; Chao, Ta-Chung TC; Lien, Pei-Ju PJ; Lin, Yen-Shu YS; Feng, Chin-Jung CJ; Chiu, Jen-Hwey JH; Hsu, Chih-Yi CY; Tseng, Ling-Ming LM

Publication Date: 2021-02-25

Variant appearance in text: PIK3CA: D1029N

PubMed Link: 33632156

Variant Present in the following documents:

• Main text
• 12885_2021_Article_7931.pdf

View BVdb publication page

---

Combined assay of Circulating Tumor DNA and Protein Biomarkers for early noninvasive detection and prognosis of Non-Small Cell Lung Cancer.

Journal Of Cancer

Yin, Jian-Xin JX; Hu, Wen-Wei WW; Gu, Hua H; Fang, Jian-Min JM

Publication Date: 2021

Variant appearance in text: PIK3CA: 3085G>A; D1029N

PubMed Link: 33442424

Variant Present in the following documents:

• jcav12p1258s2.xlsx, sheet 7

View BVdb publication page

---

Dual-molecular barcode sequencing detects rare variants in tumor and cell free DNA in plasma.

Scientific Reports

Hirotsu, Yosuke Y; Otake, Sotaro S; Ohyama, Hiroshi H; Amemiya, Kenji K; Higuchi, Rumi R; Oyama, Toshio T; Mochizuki, Hitoshi H; Goto, Taichiro T; Omata, Masao M

Publication Date: 2020-02-25

Variant appearance in text: PIK3CA: 3085G>A; D1029N

PubMed Link: 32099048

Variant Present in the following documents:

• Main text
• 41598_2020_Article_60361.pdf

View BVdb publication page

---

Patterns of genomic evolution in advanced melanoma.

Nature Communications

Birkeland, E E; Zhang, S S; Poduval, D D; Geisler, J J; Nakken, S S; Vodak, D D; Meza-Zepeda, L A LA; Hovig, E E; Myklebost, O O; Knappskog, S S; Lønning, P E PE

Publication Date: 2018-07-10

Variant appearance in text: PIK3CA: D1029N

PubMed Link: 29991680

Variant Present in the following documents:

• 41467_2018_5063_MOESM7_ESM.xlsx, sheet 1

View BVdb publication page

---

Formalin fixation increases deamination mutation signature but should not lead to false positive mutations in clinical practice.

Plos One

Prentice, Leah M LM; Miller, Ruth R RR; Knaggs, Jeff J; Mazloomian, Alborz A; Aguirre Hernandez, Rosalia R; Franchini, Patrick P; Parsa, Kourosh K; Tessier-Cloutier, Basile B; Lapuk, Anna A; Huntsman, David D; Schaeffer, David F DF; Sheffield, Brandon S BS

Publication Date: 2018

Variant appearance in text: PIK3CA: D1029N

PubMed Link: 29698444

Variant Present in the following documents:

• pone.0196434.s001.xlsx, sheet 3
• pone.0196434.s001.xlsx, sheet 2

View BVdb publication page

---

PIK3CA and TP53 mutations predict overall survival of stage II/III colorectal cancer patients.

World Journal Of Gastroenterology

Li, A-Jian AJ; Li, Hua-Guang HG; Tang, Er-Jiang EJ; Wu, Wei W; Chen, Ying Y; Jiang, Hui-Hong HH; Lin, Mou-Bin MB; Yin, Lu L

Publication Date: 2018-02-07

Variant appearance in text: PIK3CA: Asp1029Asn

PubMed Link: 29434452

Variant Present in the following documents:

• Main text
• WJG-24-631.pdf

View BVdb publication page

---